Revenue rose 10.7% year-over-year to $88.9 million, but gross margin fell to 13.4% and normalised EBITDA loss widened. Strategic initiatives, including a $6 million plant expansion and sales team growth, aim to restore profitability amid ongoing market challenges.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.